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http:WHAT THIS PAPER ADDS
The MayeHusni procedure is not a widely accepted method for venous bypass because of the small numbers of
patients with extended isolated obstruction of the femoral vein and strict criteria for the operation. Every new
experience in this ﬁeld adds more information to the understanding of the procedure and status of those
patients who require surgery.Objectives: The MayeHusni procedure is a rarely used saphenofemoral venous bypass because of the small
number of patients with post-thrombotic segmental femoral vein obstruction alone and the lack of validated
selection criteria. There are only a few institutional series reporting the use of this technique. The purpose of this
report is to present the author’s experience and critically review the literature.
Methods: Within a 13 year period 12 patients with venous claudication, skin pigmentation, and severe pain and
swelling of their legs underwent the MayeHusni procedure. Their median age was 57 years (41e69 years).
Imaging showed segmental venous obstruction of the femoral vein in all patients and poor or no inﬂow from the
deep femoral vein. Two patients were lost to follow up and the remaining 10 patients were reviewed with a
median follow up of 60 months (26e72months).
Results: The saphenopopliteal bypass remained patent in all patients at follow up. The development of reﬂux of
the saphenous conduit in four patients did not affect the clinical improvement. Venous claudication resolved,
hyper-pigmentation improved, and pain was relieved in all patients. Recanalization of the femoral vein 3 years
following thrombosis was followed by recurrence of the post-thrombotic symptoms in two patients.
Conclusions: These results indicate that a highly selected subgroup of patients with severe symptomatic post-
thrombotic syndrome secondary to chronic segmental obstruction of the femoral vein do well after the Maye
Husni procedure. In order to reﬁne the criteria for the selection of patients who may beneﬁt from this operation,
there is a need for more studies that use a combination of hemodynamic and validated scales that diagnose and
grade the severity of post-thrombotic syndrome.
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obstructionINTRODUCTION
In the vast majority of patients with post-thrombotic syn-
drome, conservative management is sufﬁcient to provide
symptomatic improvement. A small number of patients
with severe symptomatic post-thrombotic changes are
suitable for invasive interventions such as the popliteale
common femoral vein bypass procedure. This type of pro-
cedure is not widely known or accepted.1,2rresponding author. Institute of Experimental Medicine of the North
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//dx.doi.org/10.1016/j.ejvs.2015.05.010In 1954 Warren and Theodore Thayer were the ﬁrst to
suggest a bypass procedure for cases of severe symptomatic
isolated obstruction of the femoral vein.1,2 In a series of 14
patients the great saphenous vein (GSV) was transected at
the popliteal level and was anastomosed with the popliteal
vein. This saphenopopliteal vein bypass resulted in an
improvement by relieving the symptoms of post-thrombotic
syndrome (PTS) in 71% of the patients. Despite the good
results, the operation did not receive wide recognition, and
for 16 years there have been no further publications about
the technique. In 1970 Husni, May and Frileux revised the
operation. Husni was the ﬁrst to perform the anastomosis
between the GSV and the posterior tibial vein in cases of
extended obstruction. He also performed an arteriovenous
ﬁstula to improve the patency of the bypass. Since then,
this operation has been closely linked with their names.2,3
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undergo the MayeHusni procedure. This operation is only
possible if the GSV and the saphenofemoral junction remain
fully patent and in addition the common femoral and
popliteal veins are spared from post-thrombotic changes
and are patent.2,4 However, patients with segmental severe
obstruction of the femoral vein alone are uncommon, as the
post-thrombotic changes tend to be extensive in the lower
extremities in patients with severe symptomatic disease
who require surgical intervention.2
The purpose of this report is to present the author’s
experience with the MayeHusni procedure and to critically
review the literature.Figure 1. Typical patient with occluded femoral vein and severely
diseased deep femoral vein with central segmental occlusion.
DFV ¼ deep femoral vein.
Figure 2. Typical patient with patent popliteal vein.MATERIALS AND METHODS
During 1999e2012, 1,950 patients with post-thrombotic
disease were seen in the department. Only 12 patients
were identiﬁed with segmental femoral vein obstruction
alone, who were suitable for saphenopopliteal bypass using
the saphenous vein in situ. There were two women and 10
men. The median age was 57 years (41e69 years) and they
were operated on 2e5 years after the acute deep vein
thrombosis.
The patients’ clinical severity class as per CEAP (Clinical,
Etiological, Anatomical and Pathophysiological) classiﬁca-
tion was C4a in six patients and C4b in six patients. All
patients were symptomatic with pain and described venous
claudication. None had leg ulcers. Post-operatively the de-
gree of pain, cramps, heaviness, venous claudication,
edema, and hyper-pigmentation was assessed subjectively
by the patient as completely resolved, improved, same/
worse.
Patients had extensive post-thrombotic severe obstruc-
tion of the femoral vein that had been identiﬁed by Duplex
ultrasound and phlebography of the lower extremities. The
morphological ﬁndings of post-thrombotic multi-channels
with low venous ﬂow in the femoral vein were considered
to constitute hemodynamically signiﬁcant obstruction. No
hemodynamic measurements were performed.5
Decreased venous outﬂow was also visualized in the deep
femoral vein, which was not considered to be an effective
collateral pathway in all patients (Fig. 1). Patients who were
operated on fulﬁlled the following inclusion criteria: severe
signs ( C4) and symptoms including signiﬁcant pain, se-
vere segmental obstruction of the femoral vein, patent
common femoral vein, and iliocaval venous outﬂow, patent
popliteal vein (Fig. 2) with adequate inﬂow from the calf,
competent and patent great saphenous vein, and severe
post-thrombotic changes of the profunda vein with
impaired ﬂow. The median diameter of the GSV at the time
of surgery was 6.7 mm (range: 5.3e7.8 mm).
All procedures were performed by a single experienced
surgeon (E.S.) under spinal anesthesia. A longitudinal inci-
sion was made in the medial lower third of the thigh. The
popliteal vein was dissected. The GSV was transected, and
its diameter was measured and patency conﬁrmed. The GSV
was anastomosed end to side to the popliteal vein. Becauseof a fear that secondary GSV dilation with time would
compromise the outcome, a Vedensky spiral was placed
through a separate incision at the saphenofemoral conﬂu-
ence to prevent dilation and subsequent incompetence of
the pre-terminal and terminal valves in four patients later in
the study (Fig. 3).6 No arteriovenous ﬁstula was performed
in any of the cases.
In the post-operative period all the patients received
anticoagulant treatment with low molecular weight hepa-
rins in therapeutic doses (Enoxaparin sodium or Nadroparin
calcium) and then started on warfarin for 3 months. The
target level of the international normalization ratio was
Figure 3. Great saphenous vein with a Vedensky spiral near the
saphenofemoral junction.
The MayeHusni Procedure 515between 2 and 3. Anticoagulation was stopped after 3
months because of absence of thrombophilia and other
hypercoaguable conditions or permanent risk factors to
develop recurrent deep vein thrombosis. Compression
therapy was performed using Class II compression stockings
(23e32 mmHg; RAL-GZ 387 standard). Patients were
encouraged to mobilize early on the ﬁrst day after the
operation.
RESULTS
Two patients were lost to follow up. Thus, long-term results
were recorded in 10 of the 12 patients. The median follow
up was 60 months (26e72 months). All 10 patients showed
symptomatic improvement. The outcomes are shown in
Table 1. There was no peri-operative mortality or morbidity.
The post-operative length of the stay was 1e3 days.
In all patients the Duplex ultrasound showed a patent
GSV during the whole period of follow up. However, the
development of GSV incompetence was observed in four
non-Vedensky patients after 1.5e2 years. Apart from GSV
incompetence, there was no deterioration in clinical
outcome with time. The GSV remained competent without
venous reﬂux in all four patients with a Vedensky spiral.
At 1 year, two patients showed a temporary improve-
ment. After this initial improvement, all their symptoms
recurred. A venous duplex scan revealed signs of signiﬁcant
recanalization in the femoral vein associated with deepTable 1. Clinical outcome after the bypass operation, measured
subjectively by the patient at last follow-up.
Complete
resolution
(n)
Improvement
(n)
No
change/worse
(n)
Pain 10 0 0
Cramps 10 0 0
Heaviness 8 2 0
Venous claudication 10 0 0
Edema 3 7 0
Lipodermatosclerosis 0 6 2
Hyperpigmentation 0 10 0venous reﬂux. These patients were considered as possible
candidates for deep vein valve reconstructive surgery;
however, none of them came back for further treatment.DISCUSSION
Despite the current progress of reconstructive surgery for
deep veins, the MayeHusni operation still has a limited role
in the management of patients with severe post-thrombotic
syndrome. The accumulated published experience in the
past 60 years includes only 146 MayeHusni operations and
the published series have only a very small number of pa-
tients each.2,3,7,8
In 2013 D.M. Coleman published a review of the Maye
Husni procedures.2 Clinical improvement varied from 42%
to 100% (Table 2).
The large variation in clinical improvement is apparently
the result of different and subjective outcome measures in
the published series, no quality of life assessment, and
incomplete information on the indications and the timing
for the procedures. The introduction and validation of the
Villalta scale to diagnose and grade the severity of PTS
provides a valuable tool to standardize the reporting of
outcomes for MayeHusni procedures, but was not used in
this study or in previous publications.14
The results in this study are similar to other series of a
good response to the treatment as stable clinical improve-
ment was observed in 10 out of 12 patients (83%) (reten-
tion of achieved improvement of symptoms during the
period of follow up). However, patients with ulcerative skin
changes were not part of this study (C5eC6), as was the
case for Coleman and AbuRahma, which makes it impos-
sible to predict the effectiveness of saphenopopliteal
bypass in those patients in this study.
This study indicates that a stable obstruction of the
femoral vein without later recanalization is an absolute
requirement for a beneﬁcial outcome in saphenopopliteal
bypass surgery. It has been reported in previous studies that
the post-thrombotic process is completed within 3 months
to 2 years after deep vein thrombosis.15 However, in two of
the patients, recanalization of the femoral vein was
observed 3 years after deep vein thrombosis. This resulted
in the development of signiﬁcant deep femoral venous
reﬂux, which caused deterioration in the clinical condition
in spite of a patent bypass.
The hemodynamic proﬁle of the patient who is most
likely to beneﬁt from the MayeHusni procedure has not yet
been studied in detail. AbuRahma et al.4 reported that low
maximal venous outﬂow, normal and mild shortening of the
reﬁll time, external compression of the iliac vein, and
venous claudication were clinical predictors that correlate
with good clinical outcome after veno-venous bypasses, but
they cannot be used as selection criteria. It could be useful
to record the pre-operative pressure gradient between the
popliteal and common femoral vein at rest and with exer-
cise after 10 tiptoe movements and investigate whether
these static and dynamic pressure measurements correlate
with clinical improvement.16
Table 2. Review of the MayeHusni procedures.
Study Number of patients AVFa Follow up (months) Clinical improvement (%) Bypass patency (%)
Warren9 (1954) 14 e 23 71 57
Husni10 (1970) 20 e ? 70 69
Frileux11 (1972) 23 e ? 100 67
Dale12 (1979) 6 e ? 50 ?
Husni3 (1983) 27 e 12e132 78 63
Gruss13 (1985) 12 8 ? 42 ?
Danza8 (1991) 8 2 ? 75 ?
AbuRahma4 (1991) 19 e 66 58 42
Coleman2 (2013) 17 3 101 82 56
Shaydakov (2014) (unpublished data) 10 e 60 83 100
AVF ¼ arteriovenous ﬁstula.
a Modiﬁed from Coleman et al.2
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petent GSV is a useful conduit for the management of these
patients. AbuRahma et al.4 warned against the use of an
incompetent GSV, which can increase venous hypertension.
Coleman et al.2 disputed this opinion and reported that
even an incompetent GSV can provide an adequate collat-
eral route for blood outﬂow in patients with severe symp-
tomatic post-thrombotic changes of the femoral vein.
Coleman pointed out that the development of incompe-
tence of the GSV, caused by the pressure of its increasing
functional load, does not lead to the deterioration of clinical
results. In this study incompetent GSVs were not used to
create the bypass. However, the development of GSV
incompetence in four patients was observed with time and
that was the reason for placing a Vedensky spiral in order to
prevent GSV dilatation and incompetence in the following
four patients. In these patients competence of terminal and
pre-terminal valves were preserved with time, as was
shown on duplex ultrasound. In spite of similar results in
patients with and without a Vedensky spiral, further ob-
servations are required to deﬁne the role of GSV incom-
petence and the necessity of Vedensky spiral placement in
long-term outcomes.
This study has several limitations. It is a retrospective
non-randomized study with a small number of patients who
had been treated at the time when the standardized
severity scoring scale was not widely accepted. It also only
employed Duplex ultrasound and phlebography to investi-
gate the venous system. It is obvious that indications for
saphenopopliteal venous bypass are still not clear. The
experience of this study shows that patients with a com-
bination of extended femoral vein obstruction and impaired
deep femoral venous outﬂow may beneﬁt from the Maye
Husni procedure. The presence of severe post-thrombotic
signs and symptoms affecting the patient’s quality of life
and unresponsiveness to conservative treatment could be
considered as indications for saphenopopliteal bypass. The
improvement of the inﬂow (popliteal vein endo-
phlebectomy, arteriovenous ﬁstula) or the outﬂow of the
bypass (common femoral vein endophlebectomy, iliac vein
stenting, femoro-femoral crossover venous bypass) has the
potential to enhance the patency of the MayeHusni pro-
cedure.2 Raju et al.17 have reported in a recent series of 39patients that percutaneous stenting of iliac vein obstruction
associated with femoral vein occlusion yields signiﬁcant
clinical relief. The same group pointed out that iliac veins
should be examined precisely with up to date technology, as
overt or occult iliac vein lesions could be a contributor to
the symptoms in this setting.
In conclusion, the MayeHusni procedure may be indi-
cated in a small number of highly selected patients with
severe symptomatic post-thrombotic syndrome unrespon-
sive to conservative treatment. Future studies in high vol-
ume venous centers will help to better deﬁne the role of
this operation.CONFLICT OF INTEREST
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